Speaker

Zeng Wen
Professor
Army Medical University
Back to List

New Explorations in Stem Cell-Derived Extracellular Vesicles and CAR-Macrophage Therapy


【Bio】

Academic & Administrative Positions

  • Director, Department of Cell Biology, College of Basic Medical Sciences, Army Medical University

  • Assistant Director, National Key Laboratory of Trauma and Chemical Poisoning

  • Academic Director, Department of Neurology, Southwest Hospital

  • Principal Investigator (PI), Stem Cell and Tissue Regeneration Team, Jinfeng Laboratory

Honors & Funding

  • Principal Investigator of prestigious national projects, including:

    National Natural Science Foundation of China (NSFC) Distinguished Young Scholars (A-class)

    NSFC Excellent Young Scientists Fund

    National Key R&D Program for Young Scientists

    Chongqing Distinguished Young Scholars Project

  • Selected Talent: Recognized as an "Elite Academic Talent" of the Military and a "Chongqing Elite Innovation Liaison Leader."

Professional Memberships

  • Vice Chair, Tissue Engineering and Regenerative Medicine Branch, Chinese Society of Biomedical Engineering

  • Standing Committee Member & Secretary-General, Trauma Medicine Branch, China Association for Promoting Health Care

  • Vice President, Chongqing Society for Cell Biology

  • Expert Consultant: Member of the Military Science Popularization Committee and Subject Matter Expert for the Science and Technology Commission of the CMC.

Research Focus & Achievements

Mainly engaged in stem cells, tissue regeneration, and cell therapy, with a strategic focus on the basic research and clinical translation of small-diameter engineered vascular grafts.

  • Publications: Authored over 20 SCI papers in high-impact journals such as Nat Commun, Sci Adv, and Adv Mater (featured as a cover story).

  • Awards & Intellectual Property:

  • Winner of the First Prize of the Chongqing Technological Invention Award.

  • Included in the "National Top 100 Scientific Achievements by Women."

  • Holds 6 authorized national invention patents.

  • Clinical Translation: Developed original bio-artificial blood vessels (diameter < 4mm); established 2 group standards; obtained the Registration Inspection Certificate for Class III Medical Devices and NMPA Master File registration for raw materials; currently cleared for clinical trials.